Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 3Phase 1/2 3Phase 3 1

Status

Completed 2Terminated 1Suspended 1

Sponsor Class

INDUSTRY 2OTHER 1NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Lymphoid 1Breast 1

Conditions

Neoplasms 3Lymphoma 1Liver Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × eniluracil × Clear all
NCT00827580 2018-05-30

Eniluracil Hand Foot Syndrome

West Virginia University

Phase 1 Terminated
3 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT00264472 2008-12-15

A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors

Adherex Technologies, Inc.

Phase 1 Suspended
60 enrolled
Tumor-Agnostic

Neoplasms

NCT00264446 2007-08-06

A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection

Adherex Technologies, Inc.

Phase 1 Completed
Gastrointestinal

Liver Neoplasms, Neoplasms, Colorectal Neoplasms

NCT00001579 2006-07-17

A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
50 enrolled
Lymphoid

Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡